Page last updated: 2024-12-08

ad 1308

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

AD 1308: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID175033
CHEMBL ID4777258
SCHEMBL ID10606565
MeSH IDM0086735

Synonyms (18)

Synonym
quinoline, 2-(4-ethyl-1-piperazinyl)-4-phenyl-, dihydrochloride
ENAMINE_000171
OPREA1_679602
ad 1308
HMS1394H17
2-(4-ethylpiperazin-1-yl)-4-phenylquinoline
2-(4-ethyl-1-piperazinyl)-4-phenylquinoline hydrochloride
as 2646
2 (4-ethyl-1-piperazinyl)-4-phenylquinoline maleate
72320-59-3
ad-1308
SCHEMBL10606565
PHOZLMDTTWWBAH-UHFFFAOYSA-N
2-(4-ethyl-1-piperazinyl)-4-phenylquinoline
DTXSID90993114
CHEMBL4777258
AKOS040750122
PD160869
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.21 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]